Condition
Angiosarcoma Metastatic clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Angiosarcoma Metastatic clinical trials that are recruiting, at sites in 2 countries (most in Japan (1), China (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Combination therapy of pembrolizumab and lenvatinib for unresectable cutaneous angiosarcoma
This study is testing if a combination of two drugs, pembrolizumab and lenvatinib, can help people with a type of skin cancer called unresectable cutaneous angiosarcoma who haven't had success with other treatments.
-
Combining two chemotherapy drugs for advanced angiosarcoma treatment
This study is testing a new combination of two chemotherapy drugs to see if it can help people with advanced angiosarcoma who haven't had success with other treatments.
Related topics
Quick answers
How many Angiosarcoma Metastatic clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Japan (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.